Packer R J
Department of Neurology, Children's National Medical Center, Washington, DC 20010, USA.
Curr Opin Pediatr. 1996 Dec;8(6):549-57. doi: 10.1097/00008480-199612000-00003.
Primary central nervous system tumors are the second most common form of childhood cancer and the leading cancer-related cause of death and illness in children. Developments in neuroscience have led to an increasing understanding of these neoplasms, to alternations in their classification system, and to progress (albeit frustratingly slow progress) in their management. Chemotherapy has become an integral part of the treatment of many forms of childhood brain cancer, including medulloblastoma. Increasing evidence indicates that the amount of craniospinal radiation therapy required for diseases control can be reduced, possibly decreasing treatment-related sequelae, when this therapy is combined with postradiation chemotherapy. The value of the use of preradiation chemotherapy remains unproven. For other types of tumors, such as malignant high-grade gliomas and brainstem gliomas, new approaches to therapy have not yet resulted in improved outcomes. However, even for these tumors, advances in neuroimaging and new neurobiologic approaches hold substantial promise.
原发性中枢神经系统肿瘤是儿童癌症的第二常见形式,也是儿童癌症相关死亡和疾病的主要原因。神经科学的发展使人们对这些肿瘤有了越来越多的了解,其分类系统发生了变化,治疗方面也取得了进展(尽管进展令人沮丧地缓慢)。化疗已成为许多形式儿童脑癌治疗不可或缺的一部分,包括髓母细胞瘤。越来越多的证据表明,当这种疗法与放疗后化疗联合使用时,控制疾病所需的全脑全脊髓放疗量可以减少,可能会减少与治疗相关的后遗症。放疗前化疗的价值尚未得到证实。对于其他类型的肿瘤,如恶性高级别胶质瘤和脑干胶质瘤,新的治疗方法尚未带来更好的治疗效果。然而,即使对于这些肿瘤,神经影像学的进展和新的神经生物学方法也具有很大的前景。